Neuromuscular Adaptations to Exercise In Patients With Type 2 Diabetes Mellitus

Aerobic Exercise Clinical Trial

Official title:

Neuromuscular Adaptations to Exercise In Patients With Type 2 Diabetes Mellitus

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04068285
• Other study ID #: 60116787-0
• Status: Completed
• Phase: N/A
• Start date: November 4, 2019
• Est. completion date: June 1, 2020

Study information

• Verified date: June 2020
• Source: Pamukkale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to compare the effects of high intensity interval exercise and moderate intensity continuous exercise on basic gait parameters in patients with type 2 diabetes mellitus.

Description:

Volunteers with type 2 diabetes mellitus will be evaluated in terms of any contra-indication that will restrain them from making exercise. 90 male or female volunteers who are suitable in terms of inclusion/exclusion criteria will be invited for the study. Volunteers will be randomly distributed to one of the 3 groups. Each group will contain 30 participants. 1. group will make aerobic exercise which is in the form of high intensity interval exercise 2.group will make aerobic exercise which is in the form of moderate intensity continuous exercise 3. Control group. Exercise groups will be cycling under observation in the hospital setting. Control group will make simple stretching exercises at home. Participants will be requested to complete a 3 months of exercise. They will be evaluated before and at the end of the 3 months of exercise with basic gait parameters such as cadence, gait speed, stride length, percentages of swing phase and stance phase evaluated by a wireless digital miniature gait analysis system.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 72
• Est. completion date: June 1, 2020
• Est. primary completion date: June 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 60 Years

Eligibility

Inclusion Criteria:

1. Participants must have type 2 Diabetes mellitus less than 10 years and more than 1 year.

2. Participants must have appropriate medical therapy and diet.

3. Participants must not be treated with insulin.

4. Participants must be exercising less than 210 minutes/ week

Exclusion Criteria:

1. Participants with prominent cardiovascular disease

2. Participants with coronary artery disease

3. Participants with moderate to severe valvular disease

4. Participants with atrial fibrillation

5. Participants with untreated hypertension

6. Participants with congenital heart disease

7. Participants with retinopathy

8. Participants with neuropathy

9. Participants with macro albuminuria

10. Participants with cerebrovascular disease

11. Participants with ejection fraction less than 40

12. Participants with body mass index greater than 35.

13. Participants with prominent ischemic changes in EKG at rest or during exercise.

14. Participants with cigarette or alcohol addiction

15. Participants on drugs that interferes with body fat distribution (such as insulin, thiazolidinediones

Related Conditions & MeSH terms

• Aerobic Exercise
• Diabetes Mellitus
• Diabetes Mellitus, Type 2
• Gait Disorders, Neurologic
• Gait, Unsteady

Intervention

Other:
• Aerobic Exercise
Participants will be making aerobic exercise

Locations

Country	Name	City	State
Turkey	Pamukkale University	Denizli

Sponsors (1)

Lead Sponsor	Collaborator
Pamukkale University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	walking speed	change in walking speed in m/s	12 weeks